|
87
|
302
|
2wipA |
Structure of cdk2-cyclin a complexed with 8-anilino-1-methyl-4,5-dihydro- 1h-pyrazolo[4,3-h] quinazoline-3-carboxylic acid |
|
87
|
265
|
2wtvA |
Aurora-a inhibitor structure |
|
93
|
293
|
2wgjA |
X-ray structure of pf-02341066 bound to the kinase domain of c-met |
|
97
|
304
|
2wtjA |
Crystal structure of chk2 in complex with an inhibitor |
|
78
|
264
|
2wmrA |
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors |
|
86
|
302
|
2wihA |
Structure of cdk2-cyclin a with pha-848125 |
|
119
|
350
|
2wu6A |
Crystal structure of the human clk3 in complex with dki |
|
82
|
371
|
2wtkB |
Structure of the heterotrimeric lkb1-stradalpha-mo25alpha complex |
|
89
|
280
|
2wqnA |
Structure of adp-bound human nek7 |
|
85
|
302
|
2wpaA |
Optimisation of 6,6-dimethyl pyrrolo 3,4-c pyrazoles: identification of pha-793887, a potent cdk inhibitor suitable for intravenous dosing |
|
74
|
263
|
2wmtA |
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors |
|
93
|
286
|
2wkmA |
X-ray structure of pha-00665752 bound to the kinase domain of c-met |
|
95
|
303
|
2wtiA |
Crystal structure of chk2 in complex with an inhibitor |
|
89
|
302
|
2wtcA |
Crystal structure of chk2 in complex with an inhibitor |
|
88
|
281
|
2wqmA |
Structure of apo human nek7 |
|
93
|
299
|
2wouA |
Alk5 in complex with 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamide |
|
71
|
262
|
2wmuA |
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors |
|
91
|
297
|
2wmbA |
Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin a |
|
75
|
296
|
2whbA |
Truncation and optimisation of peptide inhibitors of cdk2, cyclin a through structure guided design |
|
121
|
349
|
2wo6A |
Human dual-specificity tyrosine-phosphorylation-regulated kinase 1a in complex with a consensus substrate peptide |
|
75
|
264
|
2wmsA |
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors |
|
77
|
264
|
2wmvA |
Crystal structure of checkpoint kinase 1 (chk1) in complex with inhibitors |
|
92
|
301
|
2w7xA |
Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel chk2 inhibitor pv1019 |
|
76
|
297
|
2wmaA |
Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin a |
|
80
|
295
|
2wfyA |
Truncation and optimisation of peptide inhibitors of cdk2, cyclin a through structure guided design |
|
120
|
352
|
2wb8A |
Crystal structure of haspin kinase |
|
52
|
288
|
2w9fB |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
91
|
278
|
2weiA |
Crystal structure of the kinase domain of cryptosporidium parvum calcium dependent protein kinase in complex with 3-mb-pp1 |
|
86
|
296
|
2wevA |
Truncation and optimisation of peptide inhibitors of cdk2, cyclin a through structure guided design |
|
110
|
355
|
2wajA |
Crystal structure of human jnk3 complexed with a 1-aryl-3,4- dihydroisoquinoline inhibitor |
|
86
|
290
|
2w1iA |
Structure determination of aurora kinase in complex with inhibitor |
|
92
|
292
|
2wd1A |
Human c-met kinase in complex with azaindole inhibitor |
|
57
|
289
|
2w96B |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
88
|
276
|
2w4jA |
X-ray structure of a dap-kinase 2-277 |
|
100
|
308
|
2welA |
Crystal structure of su6656-bound calcium/calmodulin-dependent protein kinase ii delta in complex with calmodulin |
|
61
|
291
|
2w9zB |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
97
|
301
|
2w4kA |
X-ray structure of a dap-kinase 2-302 |
|
77
|
298
|
2w1hA |
Fragment-based discovery of the pyrazol-4-yl urea (at9283), a multi- targeted kinase inhibitor with potent aurora kinase activity |
|
53
|
291
|
2w99B |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
87
|
277
|
2w5bA |
Human nek2 kinase atpgammas-bound |
|
93
|
304
|
2w4oA |
Crystal structure of human camk4 in complex with 4-amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide) |
|
84
|
298
|
2vtlA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
75
|
298
|
2vtsA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
88
|
301
|
2w0jA |
Crystal structure of chk2 in complex with nsc 109555, a specific inhibitor |
|
78
|
280
|
2vwvA |
Ephb4 kinase domain inhibitor complex |
|
83
|
277
|
2w5hA |
Human nek2 kinase apo |
|
80
|
298
|
2vtqA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
77
|
298
|
2vtjA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
101
|
293
|
2vz6A |
Structure of human calcium calmodulin dependent protein kinase type ii alpha (camk2a) in complex with indirubin e804 |
|
87
|
281
|
2vwxA |
Ephb4 kinase domain inhibitor complex |
